MedPath

The MobiliseMe study: Testing the effect of different smartphone activities on young people's mental health

Not Applicable
Completed
Conditions
Depressive symptoms
Anxiety symptoms
Psychological distress
Emotional well-being
Poor quality of life
Excessive, repetitive negative thinking
Poor emotion regulation
Lack of perceived need for mental health care
Mental Health - Depression
Mental Health - Anxiety
Registration Number
ACTRN12622000131752
Lead Sponsor
niversity of New South Wales (UNSW)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
569
Inclusion Criteria

Aged 12 to 17 years (confirmed by self-report);
Located in Australia (confirmed by self-report);
Experiencing mild to moderately-severe depressive symptoms (as determined by a total score of 5-19 on the self-report Patient Health Questionnaire-9- Adolescent version);
Own or have access to a smartphone (for receipt of the study interventions);
Have access to the Internet, an active email address and mobile phone number (for receipt of study activities, invitations, reminders);
Comfortable with reading English at Year 7-8 level (to ensure comprehension of intervention content);
Have a parent or guardian who can provide consent for participation.

Exclusion Criteria

Currently experiencing severe suicidal ideation (as determined by a score of greater than or equal to 2 on item 9 of the self-report Patient Health Questionnaire-9-Adolescent version).
Had serious suicidal ideation in the past month (as determined by self-report).
A suicide attempt in the past month (as determined by self-report).
Experiencing nil or severe depressive symptoms (as determined by a score total of less than or equal to 4 or greater than or equal to 20 on the self-report Patient Health Questionnaire).
Currently receiving OR about to start (in the next 2 weeks) any psychological treatment for feelings of low mood or depression from a psychologist, psychiatrist or other mental health professional
Currently taking OR about to start (in the next 2 weeks) any daily prescribed medication (e.g., anti-depressants) for their mental health (low mood, depression or anxiety).
Unable to gain parental consent to participate (as determined by failure to return parental consent form within their recruitment period).
Located outside of Australia, not within age range or fail to satisfy any of the other inclusion criteria (as determined by the self-report screener).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depressive Symptoms: This will be measured on 3 occasions using the 9-item self-report Patient Health Questionnaire: Adolescent version; PHQ-A (PHQ-A; Kroenke, 2001). The 9-item PHQ is a self-report scale that assesses the presence of depressive symptoms in the past two weeks. Item scores are summed to produce a total score, which can be used to indicate ‘nil to mild’ symptoms (scores: 0-9), ‘moderate’ symptoms (scores: 10-14), and ‘moderately severe’ to ‘severe’ symptoms (scores: 15+). The survey will available to participants for 7 days from the start of each time point.[ Timepoint 1: Baseline (Day 1)<br>Timepoint 2: Post-intervention (Primary end-point; Day 42 post-baseline completion)<br>Timepoint 3: Follow-up (Day 120 post-baseline completion)<br>]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath